ACUTE CORONARY SYNDROME (ACS)
Clinical trials for ACUTE CORONARY SYNDROME (ACS) explained in plain language.
Never miss a new study
Get alerted when new ACUTE CORONARY SYNDROME (ACS) trials appear
Sign up with your email to follow new studies for ACUTE CORONARY SYNDROME (ACS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to cut heart risk for patients with high lp(a) after heart attack
Disease control Not yet recruitingThis study tests a drug called pelacarsen in people who recently had a heart attack and have high levels of Lp(a), a type of fat in the blood that raises heart risk. The goal is to see if the drug can safely lower Lp(a) levels and improve heart health. About 240 adults in the US …
Matched conditions: ACUTE CORONARY SYNDROME (ACS)
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Shorter blood thinner course after stents may cut bleeding risk
Disease control Not yet recruitingThis study tests whether heart attack patients with high bleeding risk can safely take blood thinners for only one month after a special drug-coated stent, instead of the usual 12 months. About 468 participants will be randomly assigned to the shorter or standard therapy. The goa…
Matched conditions: ACUTE CORONARY SYNDROME (ACS)
Phase: NA • Sponsor: Shenyang Northern Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New quality check aims to reduce bleeding risks in heart patients
Knowledge-focused Not yet recruitingThis study looks at how well hospitals follow guidelines for blood thinner use after heart stent placement. It will enroll 3,500 patients with acute coronary syndrome who are at high risk for bleeding. Researchers will track their treatment and outcomes for 12 months to see if a …
Matched conditions: ACUTE CORONARY SYNDROME (ACS)
Sponsor: Shenyang Northern Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC